YLAT1 Inhibitors

Y+L amino acid transporter 1" (Y+LAT1) is a transmembrane protein intricately involved in the transport of neutral amino acids, particularly those with bulky side chains such as leucine, across cell membranes. This transporter is part of the solute carrier family and functions as an antiporter, exchanging extracellular amino acids for intracellular ones with a 1:1 stoichiometry. It typically requires the co-transport of sodium ions, which helps drive the uptake of amino acids against their concentration gradient, leveraging the sodium gradient maintained by the Na+/K+ ATPase pump.Y+LAT1 is encoded by the gene SLC7A7 and is often found associated with the heavy chain subunit 4F2hc (encoded by SLC3A2), which is essential for its proper trafficking to the plasma membrane and its functional expression. This association forms a heterodimeric amino acid transport system, which is critical for maintaining amino acid homeostasis within cells and across tissues.

The protein plays a significant role in various physiological processes, including nutrient uptake, nitrogen metabolism, and the supply of amino acids for protein synthesis. It is particularly important in tissues where rapid growth or protein turnover occurs, such as in muscle and placenta. Moreover, Y+LAT1's ability to transport large neutral amino acids like leucine makes it crucial for the activation of the mammalian target of rapamycin (mTOR) pathway, which is a key regulator of cell growth and metabolism.Mutations in the SLC7A7 gene can lead to a rare autosomal recessive disorder known as Lysinuric Protein Intolerance (LPI), characterized by the inability to properly reabsorb amino acids in the kidneys, resulting in hyperammonemia, growth retardation, and muscle hypotonia.